Skip to content

Effectiveness of ActiSight™ Needle Guidance System in Patients Undergoing CT-Guided Procedures

Phase IV Study of the ActiSight Needle Guidance System Which Assist in Guiding a Rigid Interventional Instrument Percutaneously, to a Designated Point Within the Body by Means of CT Visualization

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01148706
Acronym
ASNG
Enrollment
20
Registered
2010-06-22
Start date
2010-07-31
Completion date
2012-09-30
Last updated
2012-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Diseases, Lung Diseases

Keywords

thorax, abdomen

Brief summary

To assist in guiding a rigid interventional instrument percutaneously, to a designated point within the body by means of CT visualization.

Detailed description

The ActiSight™ Needle Guidance System is an optical navigation system designed to assist physicians performing percutaneous interventions under CT guidance. The system allows the user to select an obstacle free path to a target lesion based on pre-procedure CT images, and then provides real-time information for guiding the interventional tool towards the target along the selected path. The ActiSight™ Needle Guidance System employs a miniature video camera mounted on the needle and a reference pad attached to the skin to register the needle into the CT image space, and thus, track the needle advance towards the target. CT scans are used as needed to verify the location of the needle. The primary objective of this study is to demonstrate the effectiveness of the ActiSight™ Needle Guidance System in assisting in CT-guided percutaneous procedures.

Interventions

The ActiSight™ Needle Guidance System employs a miniature video camera mounted on the needle and a reference pad attached to the skin to register the needle into the CT image space, and thus, track the needle advance towards the target. CT scans are used as needed to verify the location of the needle.

Sponsors

ActiViews Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or female subjects, 18 years of age or older at the time of enrollment. * Subjects meeting all medical conditions for percutaneous CT guided. procedures in the chest, abdomen or pelvic, with safe path to lesion. * Written informed consent to participate in the study. * Ability to comply with the requirements of the study procedures.

Exclusion criteria

* Having co-morbidities that would clinically preclude them from an image guided procedure as determined by the operating physician. * Significant coagulopathy that cannot be adequately corrected. * Patients who have a medical contraindication to sedation (Lidocaine allergy). * Pregnancy or lactation. * Participation in an investigational trial within 30 days of enrollment.

Design outcomes

Primary

MeasureTime frame
Number of CT scans performed during the procedure, from needle insertion to final needle position in the target lesion1 Hour- During the procedure

Secondary

MeasureTime frame
Procedure time (needle dwell time in the body)1 hour -duration of the procedure

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026